(Reuters) -The U.S. Food and Drug Administration declined to approve expanded use of Acadia Pharmaceuticals Inc’s antipsychotic drug for treating psychosis related to Alzheimer’s disease, the company said on Thursday. …
(Reuters) -The U.S. Food and Drug Administration declined to approve expanded use of Acadia Pharmaceuticals Inc’s antipsychotic drug for treating psychosis related to Alzheimer’s disease, the company said on Thursday. …